Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anebulo Pharmaceuticals I...

    NASDAQ: ANEB · Real-Time Price · USD
    1.40
    -0.07 (-4.76%)
    At close: Jun 27, 2025, 11:15 AM

    Anebulo Pharmaceuticals Statistics

    Share Statistics

    Anebulo Pharmaceuticals has 41.08M shares outstanding. The number of shares has increased by 58.43% in one year.

    Shares Outstanding

    n/a
    		 41.08M

    Shares Change (YoY)

    n/a
    		 58.43%

    Shares Change (QoQ)

    n/a
    		 58.43%

    Owned by Institutions (%)

    n/a
    		 87.03%

    Shares Floating

    n/a
    		 24.43M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,782

    FTD / Avg. Volume

    n/a
    		 14.24%

    Short Selling Information

    The latest short interest is 31.34K, so 0.08% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 31.34K

    Short % of Shares Out

    n/a
    		 0.08%

    Short % of Float

    n/a
    		 0.45%

    Short Ratio (days to cover)

    n/a
    		 3.67

    Valuation Ratios

    The PE ratio is -8.44 and the forward PE ratio is -2.92. Anebulo Pharmaceuticals's PEG ratio is 0.26.

    PE Ratio

    n/a
    		 -8.44

    Forward PE

    n/a
    		 -2.92

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 18.15

    P/FCF Ratio

    n/a
    		 -8.55

    PEG Ratio

    n/a
    		 0.26
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Anebulo Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 13.46, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 13.46

    Quick Ratio

    n/a
    		 13.46

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -54.94

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,101,000

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -46.39% in the last 52 weeks. The beta is -1.16, so Anebulo Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.16

    52-Week Price Change

    n/a
    		 -46.39%

    50-Day Moving Average

    n/a
    		 1.15

    200-Day Moving Average

    n/a
    		 1.47

    Relative Strength Index (RSI)

    n/a
    		 59.6

    Average Volume (20 Days)

    n/a
    		 12,517

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -8.31M

    Net Income

    n/a
    		 -8.2M

    EBITDA

    n/a
    		 -8.05M

    EBIT

    n/a
    		 -8.05M

    Earnings Per Share (EPS)

    n/a
    		 -0.32
    Full Income Statement

    Balance Sheet

    The company has 3.09M in cash and 0 in debt, giving a net cash position of 3.09M.

    Cash & Cash Equivalents

    n/a
    		 3.09M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -65.4M

    Total Assets

    n/a
    		 14.01M

    Working Capital

    n/a
    		 13.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.09M and capital expenditures 0, giving a free cash flow of -8.09M.

    Operating Cash Flow

    n/a
    		 -8.09M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -8.09M

    FCF Per Share

    n/a
    		 -0.31
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ANEB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANEB is $5.5, which is 290.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5.5

    Price Target Difference

    n/a
    		 290.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 40.84

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist